celastrol,
tripterine,
celastrol,
34157-83-0,
Tripterine,
Tripterin,
(2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid,
Celastrol, Celastrus scandens,
UNII-L8GG98663L,
C29H38O4,
NSC70931,
NSC 70931,
CHEBI:63959,
3-Hydroxy-24-nor-2-oxo-1(10),3,5,7-friedelatetraen-29-oic Acid,
L8GG98663L,
MFCD03424073,
(2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid,
D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, (20alpha)-,
SR-05000002679,
MLS002701906,
triterpene,
Spectrum_000335,
Spectrum2_000150,
Spectrum3_000233,
Spectrum4_001966,
Spectrum5_000805,
AC1L3V4O,
SCHEMBL14954,
BSPBio_001905,
KBioGR_002436,
KBioSS_000815,
SPECTRUM201664,
MLS006011086,
DivK1c_000718,
SPBio_000260,
AC1Q6P61,
DTXSID2040993,
KBio1_000718,
KBio2_000815,
KBio2_003383,
KBio2_005951,
KBio3_001405,
KQJSQWZMSAGSHN-JJWQIEBTSA-N,
NINDS_000718,
BDBM205457,
HMS1923A13,
HMS3649E12,
BCP07973,
EBD30960,
CC0152,
CCG-39919,
NSC-70931,
s1290,
ZINC19795938,
Celastrol, >=98% (HPLC), solid,
AKOS025311497,
AC-6031,
API0001923,
CS-0409,
GS-6082,
IDI1_000718,
NCGC00178913-01,
NCGC00178913-04,
HY-13067,
NCI60_038570,
S492,
SC-19832,
SMR004702874,
LS-157465,
N1731,
ST24050307,
W-5302,
157C830,
Q-100413,
SR-05000002679-1,
SR-05000002679-3,
SR-05000002679-4,
(20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oate,
(20alpha)-3-hydroxy-2-oxo-D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid,
(2R,4aS,6aS,12bR,14aS,14bR)-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-2-picenecarboxylic acid,
1,2,3,4,4a,5,6,6a, 11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b, 14a-hexamethyl-11-oxo-2-Picenecarboxylic acid,
10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-picene-2-carboxylic acid,
2-Picenecarboxylic acid,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-,
3-Hydroxy-9.beta.,13.alpha.-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid,
3-hydroxy-9beta,13alpha-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid,
D0I9XH,
C12H16NS.Br,
2,5-Dibromo-4-methylpyridine,
CHEMBL301982,
C12-H16-N-S.Br,
KST-1A4115,
AR-1A3014,
CID122724,
ACN-035486,
C29-H38-O4,
A2604,
C2737,
C050414,
Celastrol, 98%, Protease inbibitor - 25MG 25mg,
35327-72-1,
1H-Pyrido(2,1-b)benzothiazolium, 2,3,4,4a-tetrahydro-10-methyl-, bromide,
2,3,4,4a-Tetrahydro-10-methyl-1H-pyrido(2,1-b)benzothiazolium bromide,
4a-Methyl-1,2,3,4,4a,10-hexahydropyrido(2,1-b)benzothiazolyl bromide,
(9-beta,13-alpha,14-beta,20-alpha)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid,